Form4.ai tracks every SEC insider trade in real time. See every INM insider filing with a free account — no card.
See every INM insider filing — free account, no card.
Free accountInMed Pharmaceuticals Inc. (INM) has 6 SEC Form 4 insider filings on record in the last 90 days. That includes 6 insider purchases totalling $204K. Most recent filing: Oct. 27, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Oct 27, 2026 SEC filing | ADAR1 Capital Management, LLC 10% Owner | Bought | $5 | +21.2% 7D |
| Oct 20, 2026 SEC filing | ADAR1 Capital Management, LLC 10% Owner | Bought | $1,435 | +20.5% 7D |
| Oct 15, 2026 SEC filing | ADAR1 Capital Management, LLC 10% Owner | Bought | $12,719 | +0.1% 7D |
Create a free account to see all 6 INM filings from the last 90 days. No card needed.
Create free accountWant INM insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.